Global Male Hypogonadism Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Male Hypogonadism Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Testosterone Replacement Therapy
  • 1.2.3 Gonadotropin-Releasing Hormones Therapy
• 1.3 Market by Application
  • 1.3.1 Global Male Hypogonadism Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Kallmann Syndrome
  • 1.3.3 Klinefelters Syndrome
  • 1.3.4 Pituitary Disorders
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Male Hypogonadism Market Perspective (2017-2028)
• 2.2 Male Hypogonadism Growth Trends by Region
  • 2.2.1 Male Hypogonadism Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Male Hypogonadism Historic Market Size by Region (2017-2022)
  • 2.2.3 Male Hypogonadism Forecasted Market Size by Region (2023-2028)
• 2.3 Male Hypogonadism Market Dynamics
  • 2.3.1 Male Hypogonadism Industry Trends
  • 2.3.2 Male Hypogonadism Market Drivers
  • 2.3.3 Male Hypogonadism Market Challenges
  • 2.3.4 Male Hypogonadism Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Male Hypogonadism Players by Revenue
  • 3.1.1 Global Top Male Hypogonadism Players by Revenue (2017-2022)
  • 3.1.2 Global Male Hypogonadism Revenue Market Share by Players (2017-2022)
• 3.2 Global Male Hypogonadism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Male Hypogonadism Revenue
• 3.4 Global Male Hypogonadism Market Concentration Ratio
  • 3.4.1 Global Male Hypogonadism Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Male Hypogonadism Revenue in 2021
• 3.5 Male Hypogonadism Key Players Head office and Area Served
• 3.6 Key Players Male Hypogonadism Product Solution and Service
• 3.7 Date of Enter into Male Hypogonadism Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Male Hypogonadism Breakdown Data by Type

• 4.1 Global Male Hypogonadism Historic Market Size by Type (2017-2022)
• 4.2 Global Male Hypogonadism Forecasted Market Size by Type (2023-2028)

5 Male Hypogonadism Breakdown Data by Application

• 5.1 Global Male Hypogonadism Historic Market Size by Application (2017-2022)
• 5.2 Global Male Hypogonadism Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Male Hypogonadism Market Size (2017-2028)
• 6.2 North America Male Hypogonadism Market Size by Type
  • 6.2.1 North America Male Hypogonadism Market Size by Type (2017-2022)
  • 6.2.2 North America Male Hypogonadism Market Size by Type (2023-2028)
  • 6.2.3 North America Male Hypogonadism Market Share by Type (2017-2028)
• 6.3 North America Male Hypogonadism Market Size by Application
  • 6.3.1 North America Male Hypogonadism Market Size by Application (2017-2022)
  • 6.3.2 North America Male Hypogonadism Market Size by Application (2023-2028)
  • 6.3.3 North America Male Hypogonadism Market Share by Application (2017-2028)
• 6.4 North America Male Hypogonadism Market Size by Country
  • 6.4.1 North America Male Hypogonadism Market Size by Country (2017-2022)
  • 6.4.2 North America Male Hypogonadism Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Male Hypogonadism Market Size (2017-2028)
• 7.2 Europe Male Hypogonadism Market Size by Type
  • 7.2.1 Europe Male Hypogonadism Market Size by Type (2017-2022)
  • 7.2.2 Europe Male Hypogonadism Market Size by Type (2023-2028)
  • 7.2.3 Europe Male Hypogonadism Market Share by Type (2017-2028)
• 7.3 Europe Male Hypogonadism Market Size by Application
  • 7.3.1 Europe Male Hypogonadism Market Size by Application (2017-2022)
  • 7.3.2 Europe Male Hypogonadism Market Size by Application (2023-2028)
  • 7.3.3 Europe Male Hypogonadism Market Share by Application (2017-2028)
• 7.4 Europe Male Hypogonadism Market Size by Country
  • 7.4.1 Europe Male Hypogonadism Market Size by Country (2017-2022)
  • 7.4.2 Europe Male Hypogonadism Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Male Hypogonadism Market Size (2017-2028)
• 8.2 Asia-Pacific Male Hypogonadism Market Size by Type
  • 8.2.1 Asia-Pacific Male Hypogonadism Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Male Hypogonadism Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Male Hypogonadism Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Male Hypogonadism Market Size by Application
  • 8.3.1 Asia-Pacific Male Hypogonadism Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Male Hypogonadism Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Male Hypogonadism Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Male Hypogonadism Market Size by Region
  • 8.4.1 Asia-Pacific Male Hypogonadism Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Male Hypogonadism Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Male Hypogonadism Market Size (2017-2028)
• 9.2 Latin America Male Hypogonadism Market Size by Type
  • 9.2.1 Latin America Male Hypogonadism Market Size by Type (2017-2022)
  • 9.2.2 Latin America Male Hypogonadism Market Size by Type (2023-2028)
  • 9.2.3 Latin America Male Hypogonadism Market Share by Type (2017-2028)
• 9.3 Latin America Male Hypogonadism Market Size by Application
  • 9.3.1 Latin America Male Hypogonadism Market Size by Application (2017-2022)
  • 9.3.2 Latin America Male Hypogonadism Market Size by Application (2023-2028)
  • 9.3.3 Latin America Male Hypogonadism Market Share by Application (2017-2028)
• 9.4 Latin America Male Hypogonadism Market Size by Country
  • 9.4.1 Latin America Male Hypogonadism Market Size by Country (2017-2022)
  • 9.4.2 Latin America Male Hypogonadism Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Male Hypogonadism Market Size (2017-2028)
• 10.2 Middle East & Africa Male Hypogonadism Market Size by Type
  • 10.2.1 Middle East & Africa Male Hypogonadism Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Male Hypogonadism Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Male Hypogonadism Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Male Hypogonadism Market Size by Application
  • 10.3.1 Middle East & Africa Male Hypogonadism Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Male Hypogonadism Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Male Hypogonadism Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Male Hypogonadism Market Size by Country
  • 10.4.1 Middle East & Africa Male Hypogonadism Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Male Hypogonadism Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Astrazeneca Plc.
  • 11.1.1 Astrazeneca Plc. Company Details
  • 11.1.2 Astrazeneca Plc. Business Overview
  • 11.1.3 Astrazeneca Plc. Male Hypogonadism Introduction
  • 11.1.4 Astrazeneca Plc. Revenue in Male Hypogonadism Business (2017-2022)
  • 11.1.5 Astrazeneca Plc. Recent Developments
• 11.2 Merck & Co. Inc.
  • 11.2.1 Merck & Co. Inc. Company Details
  • 11.2.2 Merck & Co. Inc. Business Overview
  • 11.2.3 Merck & Co. Inc. Male Hypogonadism Introduction
  • 11.2.4 Merck & Co. Inc. Revenue in Male Hypogonadism Business (2017-2022)
  • 11.2.5 Merck & Co. Inc. Recent Developments
• 11.3 Laboratories Genevrier
  • 11.3.1 Laboratories Genevrier Company Details
  • 11.3.2 Laboratories Genevrier Business Overview
  • 11.3.3 Laboratories Genevrier Male Hypogonadism Introduction
  • 11.3.4 Laboratories Genevrier Revenue in Male Hypogonadism Business (2017-2022)
  • 11.3.5 Laboratories Genevrier Recent Developments
• 11.4 Allergan Plc.
  • 11.4.1 Allergan Plc. Company Details
  • 11.4.2 Allergan Plc. Business Overview
  • 11.4.3 Allergan Plc. Male Hypogonadism Introduction
  • 11.4.4 Allergan Plc. Revenue in Male Hypogonadism Business (2017-2022)
  • 11.4.5 Allergan Plc. Recent Developments
• 11.5 Endo International Plc.
  • 11.5.1 Endo International Plc. Company Details
  • 11.5.2 Endo International Plc. Business Overview
  • 11.5.3 Endo International Plc. Male Hypogonadism Introduction
  • 11.5.4 Endo International Plc. Revenue in Male Hypogonadism Business (2017-2022)
  • 11.5.5 Endo International Plc. Recent Developments
• 11.6 Ferring
  • 11.6.1 Ferring Company Details
  • 11.6.2 Ferring Business Overview
  • 11.6.3 Ferring Male Hypogonadism Introduction
  • 11.6.4 Ferring Revenue in Male Hypogonadism Business (2017-2022)
  • 11.6.5 Ferring Recent Developments
• 11.7 AbbVie Inc.
  • 11.7.1 AbbVie Inc. Company Details
  • 11.7.2 AbbVie Inc. Business Overview
  • 11.7.3 AbbVie Inc. Male Hypogonadism Introduction
  • 11.7.4 AbbVie Inc. Revenue in Male Hypogonadism Business (2017-2022)
  • 11.7.5 AbbVie Inc. Recent Developments
• 11.8 Eli Lilly and Company Ltd.
  • 11.8.1 Eli Lilly and Company Ltd. Company Details
  • 11.8.2 Eli Lilly and Company Ltd. Business Overview
  • 11.8.3 Eli Lilly and Company Ltd. Male Hypogonadism Introduction
  • 11.8.4 Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2017-2022)
  • 11.8.5 Eli Lilly and Company Ltd. Recent Developments
• 11.9 Finox Biotech
  • 11.9.1 Finox Biotech Company Details
  • 11.9.2 Finox Biotech Business Overview
  • 11.9.3 Finox Biotech Male Hypogonadism Introduction
  • 11.9.4 Finox Biotech Revenue in Male Hypogonadism Business (2017-2022)
  • 11.9.5 Finox Biotech Recent Developments
• 11.10 Teva Pharmaceutical Industries Ltd.
  • 11.10.1 Teva Pharmaceutical Industries Ltd. Company Details
  • 11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
  • 11.10.3 Teva Pharmaceutical Industries Ltd. Male Hypogonadism Introduction
  • 11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2017-2022)
  • 11.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
• 11.11 Bayer AG
  • 11.11.1 Bayer AG Company Details
  • 11.11.2 Bayer AG Business Overview
  • 11.11.3 Bayer AG Male Hypogonadism Introduction
  • 11.11.4 Bayer AG Revenue in Male Hypogonadism Business (2017-2022)
  • 11.11.5 Bayer AG Recent Developments
• 11.12 IBSA Institut Biochimque
  • 11.12.1 IBSA Institut Biochimque Company Details
  • 11.12.2 IBSA Institut Biochimque Business Overview
  • 11.12.3 IBSA Institut Biochimque Male Hypogonadism Introduction
  • 11.12.4 IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2017-2022)
  • 11.12.5 IBSA Institut Biochimque Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Male Hypogonadism Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Testosterone Replacement Therapy
• Table 3. Key Players of Gonadotropin-Releasing Hormones Therapy
• Table 4. Global Male Hypogonadism Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 5. Global Male Hypogonadism Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 6. Global Male Hypogonadism Market Size by Region (2017-2022) & (US$ Million)
• Table 7. Global Male Hypogonadism Market Share by Region (2017-2022)
• Table 8. Global Male Hypogonadism Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 9. Global Male Hypogonadism Market Share by Region (2023-2028)
• Table 10. Male Hypogonadism Market Trends
• Table 11. Male Hypogonadism Market Drivers
• Table 12. Male Hypogonadism Market Challenges
• Table 13. Male Hypogonadism Market Restraints
• Table 14. Global Male Hypogonadism Revenue by Players (2017-2022) & (US$ Million)
• Table 15. Global Male Hypogonadism Revenue Share by Players (2017-2022)
• Table 16. Global Top Male Hypogonadism by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Male Hypogonadism as of 2021)
• Table 17. Ranking of Global Top Male Hypogonadism Companies by Revenue (US$ Million) in 2021
• Table 18. Global 5 Largest Players Market Share by Male Hypogonadism Revenue (CR5 and HHI) & (2017-2022)
• Table 19. Key Players Headquarters and Area Served
• Table 20. Key Players Male Hypogonadism Product Solution and Service
• Table 21. Date of Enter into Male Hypogonadism Market
• Table 22. Mergers & Acquisitions, Expansion Plans
• Table 23. Global Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
• Table 24. Global Male Hypogonadism Revenue Market Share by Type (2017-2022)
• Table 25. Global Male Hypogonadism Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 26. Global Male Hypogonadism Revenue Market Share by Type (2023-2028)
• Table 27. Global Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
• Table 28. Global Male Hypogonadism Revenue Share by Application (2017-2022)
• Table 29. Global Male Hypogonadism Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 30. Global Male Hypogonadism Revenue Share by Application (2023-2028)
• Table 31. North America Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
• Table 32. North America Male Hypogonadism Market Size by Type (2023-2028) & (US$ Million)
• Table 33. North America Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
• Table 34. North America Male Hypogonadism Market Size by Application (2023-2028) & (US$ Million)
• Table 35. North America Male Hypogonadism Market Size by Country (2017-2022) & (US$ Million)
• Table 36. North America Male Hypogonadism Market Size by Country (2023-2028) & (US$ Million)
• Table 37. Europe Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
• Table 38. Europe Male Hypogonadism Market Size by Type (2023-2028) & (US$ Million)
• Table 39. Europe Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
• Table 40. Europe Male Hypogonadism Market Size by Application (2023-2028) & (US$ Million)
• Table 41. Europe Male Hypogonadism Market Size by Country (2017-2022) & (US$ Million)
• Table 42. Europe Male Hypogonadism Market Size by Country (2023-2028) & (US$ Million)
• Table 43. Asia Pacific Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
• Table 44. Asia Pacific Male Hypogonadism Market Size by Type (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Male Hypogonadism Market Size by Application (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Male Hypogonadism Market Size by Region (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Male Hypogonadism Market Size by Region (2023-2028) & (US$ Million)
• Table 49. Latin America Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
• Table 50. Latin America Male Hypogonadism Market Size by Type (2023-2028) & (US$ Million)
• Table 51. Latin America Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
• Table 52. Latin America Male Hypogonadism Market Size by Application (2023-2028) & (US$ Million)
• Table 53. Latin America Male Hypogonadism Market Size by Country (2017-2022) & (US$ Million)
• Table 54. Latin America Male Hypogonadism Market Size by Country (2023-2028) & (US$ Million)
• Table 55. Middle East and Africa Male Hypogonadism Market Size by Type (2017-2022) & (US$ Million)
• Table 56. Middle East and Africa Male Hypogonadism Market Size by Type (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Male Hypogonadism Market Size by Application (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Male Hypogonadism Market Size by Application (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Male Hypogonadism Market Size by Country (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Male Hypogonadism Market Size by Country (2023-2028) & (US$ Million)
• Table 61. Astrazeneca Plc. Company Details
• Table 62. Astrazeneca Plc. Business Overview
• Table 63. Astrazeneca Plc. Male Hypogonadism Product
• Table 64. Astrazeneca Plc. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 65. Astrazeneca Plc. Recent Developments
• Table 66. Merck & Co. Inc. Company Details
• Table 67. Merck & Co. Inc. Business Overview
• Table 68. Merck & Co. Inc. Male Hypogonadism Product
• Table 69. Merck & Co. Inc. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 70. Merck & Co. Inc. Recent Developments
• Table 71. Laboratories Genevrier Company Details
• Table 72. Laboratories Genevrier Business Overview
• Table 73. Laboratories Genevrier Male Hypogonadism Product
• Table 74. Laboratories Genevrier Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 75. Laboratories Genevrier Recent Developments
• Table 76. Allergan Plc. Company Details
• Table 77. Allergan Plc. Business Overview
• Table 78. Allergan Plc. Male Hypogonadism Product
• Table 79. Allergan Plc. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 80. Allergan Plc. Recent Developments
• Table 81. Endo International Plc. Company Details
• Table 82. Endo International Plc. Business Overview
• Table 83. Endo International Plc. Male Hypogonadism Product
• Table 84. Endo International Plc. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 85. Endo International Plc. Recent Developments
• Table 86. Ferring Company Details
• Table 87. Ferring Business Overview
• Table 88. Ferring Male Hypogonadism Product
• Table 89. Ferring Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 90. Ferring Recent Developments
• Table 91. AbbVie Inc. Company Details
• Table 92. AbbVie Inc. Business Overview
• Table 93. AbbVie Inc. Male Hypogonadism Product
• Table 94. AbbVie Inc. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 95. AbbVie Inc. Recent Developments
• Table 96. Eli Lilly and Company Ltd. Company Details
• Table 97. Eli Lilly and Company Ltd. Business Overview
• Table 98. Eli Lilly and Company Ltd. Male Hypogonadism Product
• Table 99. Eli Lilly and Company Ltd. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 100. Eli Lilly and Company Ltd. Recent Developments
• Table 101. Finox Biotech Company Details
• Table 102. Finox Biotech Business Overview
• Table 103. Finox Biotech Male Hypogonadism Product
• Table 104. Finox Biotech Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 105. Finox Biotech Recent Developments
• Table 106. Teva Pharmaceutical Industries Ltd. Company Details
• Table 107. Teva Pharmaceutical Industries Ltd. Business Overview
• Table 108. Teva Pharmaceutical Industries Ltd. Male Hypogonadism Product
• Table 109. Teva Pharmaceutical Industries Ltd. Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 110. Teva Pharmaceutical Industries Ltd. Recent Developments
• Table 111. Bayer AG Company Details
• Table 112. Bayer AG Business Overview
• Table 113. Bayer AG Male Hypogonadism Product
• Table 114. Bayer AG Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 115. Bayer AG Recent Developments
• Table 116. IBSA Institut Biochimque Company Details
• Table 117. IBSA Institut Biochimque Business Overview
• Table 118. IBSA Institut Biochimque Male Hypogonadism Product
• Table 119. IBSA Institut Biochimque Revenue in Male Hypogonadism Business (2017-2022) & (US$ Million)
• Table 120. IBSA Institut Biochimque Recent Developments
• Table 121. Research Programs/Design for This Report
• Table 122. Key Data Information from Secondary Sources
• Table 123. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Male Hypogonadism Market Share by Type: 2021 VS 2028
• Figure 2. Testosterone Replacement Therapy Features
• Figure 3. Gonadotropin-Releasing Hormones Therapy Features
• Figure 4. Global Male Hypogonadism Market Share by Application: 2021 VS 2028
• Figure 5. Kallmann Syndrome Case Studies
• Figure 6. Klinefelters Syndrome Case Studies
• Figure 7. Pituitary Disorders Case Studies
• Figure 8. Others Case Studies
• Figure 9. Male Hypogonadism Report Years Considered
• Figure 10. Global Male Hypogonadism Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 11. Global Male Hypogonadism Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Male Hypogonadism Market Share by Region: 2021 VS 2028
• Figure 13. Global Male Hypogonadism Market Share by Players in 2021
• Figure 14. Global Top Male Hypogonadism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Male Hypogonadism as of 2021)
• Figure 15. The Top 10 and 5 Players Market Share by Male Hypogonadism Revenue in 2021
• Figure 16. North America Male Hypogonadism Market Size YoY (2017-2028) & (US$ Million)
• Figure 17. North America Male Hypogonadism Market Size Market Share by Type (2017-2028)
• Figure 18. North America Male Hypogonadism Market Size Market Share by Application (2017-2028)
• Figure 19. North America Male Hypogonadism Market Size Share by Country (2017-2028)
• Figure 20. United States Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 21. Canada Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 22. Europe Male Hypogonadism Market Size YoY (2017-2028) & (US$ Million)
• Figure 23. Europe Male Hypogonadism Market Size Market Share by Type (2017-2028)
• Figure 24. Europe Male Hypogonadism Market Size Market Share by Application (2017-2028)
• Figure 25. Europe Male Hypogonadism Market Size Share by Country (2017-2028)
• Figure 26. Germany Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. France Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. U.K. Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. Italy Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Russia Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Nordic Countries Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Asia-Pacific Male Hypogonadism Market Size YoY (2017-2028) & (US$ Million)
• Figure 33. Asia Pacific Male Hypogonadism Market Size Market Share by Type (2017-2028)
• Figure 34. Asia Pacific Male Hypogonadism Market Size Market Share by Application (2017-2028)
• Figure 35. Asia Pacific Male Hypogonadism Market Size Share by Region (2017-2028)
• Figure 36. China Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. Japan Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. South Korea Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. Southeast Asia Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. India Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Australia Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 42. Latin America Male Hypogonadism Market Size YoY (2017-2028) & (US$ Million)
• Figure 43. Latin America Male Hypogonadism Market Size Market Share by Type (2017-2028)
• Figure 44. Latin America Male Hypogonadism Market Size Market Share by Application (2017-2028)
• Figure 45. Latin America Male Hypogonadism Market Size Share by Country (2017-2028)
• Figure 46. Mexico Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 47. Brazil Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 48. Middle East & Africa Male Hypogonadism Market Size YoY (2017-2028) & (US$ Million)
• Figure 49. Middle East and Africa Male Hypogonadism Market Size Market Share by Type (2017-2028)
• Figure 50. Middle East and Africa Male Hypogonadism Market Size Market Share by Application (2017-2028)
• Figure 51. Middle East and Africa Male Hypogonadism Market Size Share by Country (2017-2028)
• Figure 52. Turkey Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. Saudi Arabia Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. UAE Male Hypogonadism Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. Astrazeneca Plc. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 56. Merck & Co. Inc. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 57. Laboratories Genevrier Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 58. Allergan Plc. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 59. Endo International Plc. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 60. Ferring Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 61. AbbVie Inc. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 62. Eli Lilly and Company Ltd. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 63. Finox Biotech Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 64. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 65. Bayer AG Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 66. IBSA Institut Biochimque Revenue Growth Rate in Male Hypogonadism Business (2017-2022)
• Figure 67. Bottom-up and Top-down Approaches for This Report
• Figure 68. Data Triangulation
• Figure 69. Key Executives Interviewed